Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 12, 2007, Pages 1404-1412

  Maróstica, Marta ^a   Arçari, Demetrius Paiva ^a   Bartchewsky Jr , Waldemar ^a   Trevisan, Miriam ^b   Ribeiro, Marcelo Lima ^a   Pedrazzoli Jr , José ^a   Hoehr, Nelci Fenalti ^c   Gambero, Alessandra ^a  

^a Universidade Sao Francisco Centro de Ciencias Biologicas e da Saude   (Brazil)

^b Multpat   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Apoptosis; Comet assay; DNA damage; Neutrophil; Omeprazole; Ranitidine

Indexed keywords

ANTACID AGENT; MYELOPEROXIDASE; OMEPRAZOLE; PROTEIN BAX; PROTEIN BCL 2; RANITIDINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; DNA DAMAGE; HELICOBACTER PYLORI; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORUS LIGATION; STOMACH ACID; STOMACH MUCOSA;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ULCER AGENTS; BLOTTING, WESTERN; COMET ASSAY; DNA DAMAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; MICE; MICE, INBRED C57BL; OMEPRAZOLE; RANITIDINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 36249021451     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701514396     Document Type: Article

References (42)

1. Abdel-Salam OM, Czimmer J, Debreceni A, Szolcsanyi J, Mozsik G. Gastric mucosal integrity: gastric mucosal blood flow and microcirculation. An overview. J Physiol Paris 2001;95:105-27.
2. Penta R, De Falco M, Iaquinto G, De Luca A. Helicobacter pylori and gastric epithelial cells: from gastritis to cancer. J Exp Clin Cancer Res 2005;24:337-45.
3. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38:498-501.
4. Mizuki I, Shimoyama T, Fukuda S, Liu Q, Nakaji S, Munakata A. Association of gastric epithelial apoptosis with the ability of Helicobacter pylori to induce a neutrophil oxidative burst. J Med Microbiol 2000;49:521-4.
5. Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996;56:1279-82.
6. Knaapen AM, Seiler F, Schilderman PA, Nehls P, Bruch J, Schins RP, et al. Neutrophils cause oxidative DNA damage in alveolar epithelial cells. Free Radic Biol Med 1999;27:234-40.
7. Ulmer HJ, Beckerling A, Gatz G. Recent use of proton pump inhibitor-based triple therapies for the eradication of Helicobacter pylori: a broad data review. Helicobacter 2003;8:95-104.
8. Koivisto TT, Rautelin HI, Voutilainen ME, Heikkinen MT, Koskenpato JP, Farkkila MA. First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. Aliment Pharmacol Ther 2005;21:773-82.
9. Robinson M. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Int J Clin Pract 2005;59:709-15.
10. 2-antagonists for treatment of GI bleeding. Ann Pharmacother 2003;37:433-7.
11. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 2003;278:10993-11001.
12. Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, et al. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 2004;195:62-72.
13. Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, et al. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 2006;17:89-93.
14. Wandall JH. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome B-245. Gut 1992;33:617-21.
15. Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 1999;21:727-31.
16. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors: inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 2000;1:74-81.
17. Agastya G, West BC, Callahan JM. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 2000;22:357-72.
18. 2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines. Dig Dis Sci 2004;49:1634-40.
19. Slomiany BL, Piotrowski J, Slomiany A. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents. J Physiol Pharmacol 1999;50:197-210.
20. Okajima K, Harada N, Uchiba M. Ranitidine reduces ischemia/reperfusion- induced liver injury in rats by inhibiting neutrophil activation. J Pharmacol Exp Ther 2002;301:1157-65.
21. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, et al. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions. Anesth Analg 1999;89:218-24.
22. Shay H, Komarov AS, Fels SS, Meranze D, Gruenstein M, Siplet H. A simple method for the uniform production of gastric ulceration in rats. Gastroenterology 1945;5:43-61.
23. Gamberini MT, Skorupa LA, Souccar C, Lapa AJ. Inhibition of gastric secretion by a water extract from Baccharis triptera, Mart. Mem Inst Oswaldo Cruz 1991;86:137-9.
24. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
25. Pool-Zobel BL, Lotzmann N, Knoll M, Kuchenmeister F, Lambertz R, Leucht U, et al. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ Mol Mutagen 1994;24:23-45.
26. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-21.
27. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;184-91.
28. Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+/K+)ATPase. Nature 1981;290:159-61.
29. 2-receptor antagonist after bleeding from a gastric ulcer. J Gastroenterol 2003;38:844-8.
30. Chattopadhyay I, Nandi B, Chatterjee R, Biswas K, Bandyopadhyay U, Banerjee RK. Mechanism of antiulcer effect of Neem (Azadirachta indica) leaf extract: effect on H+-K+-ATPase, oxidative damage and apoptosis. Inflammopharmacology 2004;12:153-76.
31. Danon SJ, O'Rourke JL, Moss ND, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 1995;108:1386-95.
32. Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. Gastroenterology 2002;122:119-33.
33. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-97.
34. van Doorn NE, Namavar F, Sparrius M, Stoof J, van Rees EP, van Doorn LJ, et al. Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun 1999;67:3040-6.
35. Elizalde JI, Mendez A, Gomez J, del Rivero M, Gironella M, Closa D, et al. Gastric mucosal blood flow changes in Helicobacter pylori infection and NSAID-induced gastric injury. Helicobacter 2003;8:124-31.
36. Martins de Oliveira R, Antunes E, Pedrazzoli J Jr, Gambero A. The inhibitory effects of H+K+ATPase inhibitors on human neutrophils in vitro: Restoration by a K+ ionophore. Inflammation Res 2007. In press.
37. Becker TL, Marostica M, Ribeiro ML, de Mendonca S, Gambero A, Pedrazzoli J Jr. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo. Int Immunopharmacol 2004;4:1051-7.
38. Wadstrom T, Rydberg J, Rozalska B, Lelwala-Guruge J. Intravenous Helicobacter pylori induces low levels of TNF-alpha and IL-1 alpha in a murine model. APMIS 1994;102:49-52.
39. Martin DA, Elkon KB. Mechanisms of apoptosis. Rheum Dis Clin North Am 2004;30:441-54.
40. Nam KT, Hahm KB, Oh SY, Yeo M, Han SU, Ahn B, et al. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 2004;10:8105-13.
41. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, et al. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 2003;18:45-51.
42. Brambilla G, Cavanna M, Faggin P, Maura A, Pino A, Ricci R, et al. Genotoxic effects in rodents given high oral doses of ranitidine and sodium nitrite. Carcinogenesis 1983;4:1281-5.